GPs could be influenced by pharma, King's Fund warns

packets of pills

GP prescribing could become commercially biased if clinical commissioning groups buy in support from drug companies, a report commissioned by the King’s Fund has warned.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here